Gastroscopic evaluation of the effects of nabumetone on the gastrointestinal mucosa of rheumatic patients.
Endoscopic studies with nabumetone have consistently shown a lower incidence of gastro-duodenal erosive lesions than comparable non-steroidal anti-inflammatory drugs (NSAIDs) including naproxen and ibuprofen.